NEW YORK (GenomeWeb News) – BioCat said today it has signed an exclusive deal to distribute Alpco Diagnostics' products in Germany.

Salem, NH-based Alpco develops metabolism assays, including insulin ELISA kits, as well as assays for factors involved in diabetes, obesity, and cardiovascular diseases. Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.